Some major procedures and an assessment of their impact in the field
Robotics in HPB surgery T he majority of major HPB operations are still performed using an open surgical approach, with large incisions contributing towards the morbidity of the procedure. The adoption of laparoscopic surgery has reduced the morbidity associated with large incisions in many different surgical specialties, but has had a relatively small impact on HPB surgery. The complex nature of this form of surgery, which demands fine manipulation of deep structures intimately related to major vessels, has appropriately resulted in a cautious and patchy adoption of the minimally invasive approach.
The inherent limitations of laparoscopic surgery, including rigid instruments and 2D vision, appear to prevent widespread adoption of this approach. Robotic surgery -with its well-described advantages over laparoscopic surgery, including 3D high-definition surgical vision, tremor filtration, motion-scaling, and an internal articulated endo-wrist 1 -promises to overcome the technical limitations of laparoscopic surgery and may permit the minimally invasive approach to be extended to major HPB surgery.
Even if such techniques are shown to be feasible in high-volume enthusiastic centres, outcomes may not be reproducible in the wider HPB community; meticulous consideration must be given to safety, and oncological and economic factors before advocating widespread adoption. The ultimate test for such new technology is whether or not surgery performed robotically can prolong disease-specific survival in major HPB surgery. In pancreatic cancer, for example, shorter recovery times following robotic surgery may permit a greater proportion of patients to receive adjuvant chemotherapy within two months, and thus extend survival. In the treatment of colorectal liver metastasis, robotic surgery may permit a parenchymal-preserving strategy to be adopted more frequently, which again has the potential to improve disease-specific survival.
is typically placed supine in a 15° reverse Trendelenburg position, with a 30° robotic camera placed to the right of the umbilicus for a right hepatectomy and to the left of the umbilicus for a left hepatectomy. Three robotic working ports and an assistant port are inserted as shown in Fig 1. Liver mobilisation is performed using an energy device and diathermy. Division of short hepatic veins during a right hepatectomy can be performed either using ligaclips or transfixion with 4-0 polypropylene suture. Hilar dissection is followed by division of the appropriate portal and arterial inflow vessels with Hem-o-lok clips or a vascular stapler device. The bile duct is usually divided during parenchymal transection. The transection plane is marked along the line of demarcation with diathermy. Division of the parenchyma is performed with a combination of Cavitron Ultrasonic Surgical Aspirator (CUSA), diathermy and energy device according to surgeon preference. The remaining hepatic vein is then divided with a vascular stapling device and over-sewn if required. The specimen is placed in a retrieval bag and, after undocking the robotic arms, removed via a Pfannenstiel incision.
Pancreatic resection
For a pancreatico-duodenectomy (PD), the patient is placed in a 15° reverse Trendelenburg position, with a 30° robotic camera to the left of the umbilicus, and three robotic ports and two assistant ports placed as shown in Fig 1(D) . Complete mobilisation of the pancreas, including division of the gastro-colic ligament and kocherisation of the duodenum, is performed with diathermy and an energy device. Division of the stomach and jejunum is performed with an endo-GIA stapler, and the jejunal mesentery with an energy device. The gastro-duodenal artery is isolated and divided with Hem-o-lok clips or a vascular stapler. Following hilar dissection, the common hepatic duct is divided sharply. The pancreatic neck is then divided using an energy device, with sharp division of the pancreatic duct. The uncinate process is divided with an energy device and the specimen placed in a retrieval bag. There are a wide variety of reconstruction techniques that can nearly all be reproduced robotically.
For a distal pancreatectomy (DP), the patient is positioned in right semi-lateral position. Five ports are used: 3 8mm robotic arms, a 12mm camera port, and an assistant port Fig 1(C) . After mobilisation of the pancreas, an endoscopic linear stapler is normally used to divide the pancreas. A row of 3-0 Polypropylene sutures is sometimes placed over the end of the pancreas, according to surgeon preference. The remainder of the operation is similar to that of laparoscopic procedure.
Pancreas surgery
Distal pancreatectomy (DP) DP intuitively lends itself to a minimally invasive approach because the procedure does not require a complex A B D C reconstruction. Furthermore, DP is an indication for patients with borderline malignant and benign tumours, in whom long-term survival is expected, and quality-of-life outcomes and the long-term immunological benefits of spleen preservation are emphasised. However, since the first laparoscopic DP (LDP) in 1996 3 , the approach has been tentatively adopted and currently accounts for only 12.6% of DPs performed. 4 Spleen preservation during DP requires separation of the pancreatic parenchyma from the closely adhered splenic vein by division of small, fragile splenic tributary veins. This is a challenging step laparoscopically because tremor is amplified by long laparoscopic instruments fulcrumed over the abdominal wall port site. Traction injury causing even a small hole in the splenic vein typically results in significant bleeding, which obscures the view and often necessitates conversion both to open surgery and splenectomy. The improved ergonomics, tremor control and motion-scaling afforded by robotic surgery may overcome this technical pitfall to a certain extent (Fig 2) .
Easy bleeding during traction of pancreas (due to the lack of haptic feedback characteristic of robotic surgery) has been described early in the learning curve. Reports suggest that this was more than compensated for by the increased visual feedback provided by magnified 3D vision 6-8 overall, because it offered greater control of the splenic vein and its tributaries. These early observations and anecdotal reports are now supported by the outcomes from non-randomised comparisons of robotic distal pancreatectomy (RDP) vs LDP. In a recent meta-analysis, 9 splenic preservation rates were increased in RDP (106/198 [53.6%] Lower conversion rates for RDP inevitably translate to other favourable outcomes such as reduced hospital length of stay (LOS) and, as a consequence, overall cost. Following the introduction of LDP, despite higher initial start-up costs, LDP was ultimately shown to be significantly less costly compared with ODP owing to a shorter LOS in the LDP group.
11 Similarly, parallels may be drawn with RDP, which is reported to have a mean LOS of 7.18 days. This is significantly shorter than 9.08 days in the LDP group (p<0.001), 9 presumably owing to a lower rate of open conversion. One cost analysis study suggests that such a reduction was enough to entirely offset the high direct operative costs of robotic surgery.
12 Ielpo et al also demonstrated the same offsetting of high start-up costs associated with RDP as reduced LOS, as well as reduced use of surgical staplers and energy devices compared with LDP. 13 However, other studies suggest RDP is considerably more costly than LDP, owing to start-up and maintenance costs -although there is wide variation in cost calculation methodology and assumptions. Kang et al provide a Korean perspective, reporting a 2.5-fold increase in costs with RDP compared with LDP. However, costs of the da Vinci robot have reduced since this time and may no longer be an accurate reflection. expenses, but failed to take into consideration differences in postoperative costs such as LOS. Furthermore, with robotic surgery increasingly being used by different specialties within hospitals, the amortised cost per case for robotic surgery is likely to fall further in the same way it has for laparoscopic surgery.
In addition to material costs and LOS, operating time is also a contributor to the overall cost. Most studies report a significantly longer operating time for RDP compared with LDP, 8, [12] [13] [14] [16] [17] [18] which may in part be due to the 30 minutes required to dock and undock the robot, and in part due to the learning curve effect in RDP. In the largest series by Zureikat et al including 83 RDP, longer operating times are reported early in the series but eventually become equivalent to both the LDP and OPD series by the end of the 4-year experience. Retrospective case series comparisons have failed to demonstrate any significant difference in PF rates between LDP and ODP. 10, 12, [14] [15] [16] [17] [18] [21] [22] [23] [24] Carochi et al 25 considered 5 non-randomised studies of RDP vs ODP including 155 patients, which also showed no difference in PF rate -this was later confirmed in a meta-analysis.
9 Although disappointing, it is not an entirely surprising outcome because intuitively neither robotic nor laparoscopic surgery offers advantages over the open approach in terms of the ability to close the remnant pancreas. In the same year in the US, Melvin and Needleman published a report of the robotic resection of a pancreatic neuroendocrine tumour. Currently, the largest series comes from Zureikat et al, 8 with 132 RPDs. In this series of selected patients, a 90-mortality of 3.8% was reported, which is well within the confidence limits of reported laparoscopic and open series. In terms of morbidity, the authors observed a significant decrease in major complications (Clavien-Dindo III-IV) in the last 40 cases -27/88 (30%) vs 6/44 (16%); p< 0.05 -suggesting the presence of a learning curve. In a large retrospective unmatched national cohort analysis of patients undergoing RPD (193) and LPD (235), the conversion rate was found to be lower -11.4% vs 26.0% respectively; p= 0.004 -but no difference was seen between the approaches in adjusted overall complications. 28 It is unlikely that randomised controlled trials assessing RPD will be feasible. Propensity-ranked comparisons of robotic, laparoscopic and open technologies from centres experienced in RDP are anticipated, and may be able to shed some light on the feasibility of RPD in terms of safety, oncology and cost, which at present are unclear.
Pancreato-duodenectomy

Prolong disease-specific survival by increasing the proportion of patients going on to receive adjuvant therapy in a timely manner
Robotic surgery has been described for the less common pancreatic resections, including median pancreatectomy 5 and total pancreatectomy.
28,5
Drawing conclusions beyond technical feasibility is not possible with such small numbers.
Impact for pancreatic surgery
The prospect of offering minimally invasive surgery to patients undergoing PD is attractive, with the potential not only to reduce morbidity but also prolong disease-specific survival by increasing the proportion of patients going on to receive adjuvant therapy in a timely manner. Although there is a competitive desire among surgeons and institutions to implement new minimally invasive techniques to improve patient outcomes, rapid introduction of novel techniques could have the opposite effect if premature. 28 Even experienced centres have shown a higher rate of significant morbidity early in the series of RPD. Propensity-ranked comparisons of robotic, laparoscopic, and open approaches for RPD are eagerly awaited.
Robotic surgery promises to have a considerable impact for patients undergoing DP for benign and borderline malignant indications where spleen preservation is favoured. The higher spleen preservation and lower conversion-to-open rates provide tangible benefits to patients and may yet prove to be equivalent or cheaper in overall cost. In malignant indications, where en-bloc splenectomy is indicated, the benefits of RDP are less clear.
Liver surgery
Minimally invasive surgery of the liver is particularly challenging, owing to the organ's deep anatomical location, size, vascularity and intimate relation to major vascular structures. It can also be difficult to maintain a complete appreciation of the complex biliary and vascular network, and ligate fragile vessels during parenchymal division. The first use of laparoscopy for liver surgery was reported by Reick in 1991. 30 Since then, as with most other surgical disciplines, several case-matched series have shown the laparoscopic approach to be feasible 31 with advantages now familiar to laparoscopic surgery, including reduced blood loss, shorter LOS with comparable safety and oncological outcomes.
32
Despite the feasibility of major (defined as three or more contiguous segments) laparoscopic hepatic resections in experienced high-volume centres, 33 laparoscopic right and left hepatectomies account for only 9% and 7% of liver resections, respectively. The vast majority of laparoscopic liver surgery is accounted for by non-anatomical sectionectomies and left lateral resection (LLR). 31 Arguably, patients undergoing major hepatectomies have the most to gain from the minimally invasive approach. The previously described advantages of robotic surgery may be suited to tackling these challenges, potentially extending the benefits of minimally invasive surgery to a higher proportion of patients undergoing liver resections. However, conclusive evidence of these benefits over open surgery from prospective randomised trials is lacking.
Left lateral resection
Resection of the left lateral section (Couinaud Segments II and II) is the simplest anatomic liver resection and the most conducive to minimally invasive surgery. The lobe is relatively easy to mobilise, does not have a close anatomical relationship with major vascular structures, and does not routinely require hilar dissection, which can be tedious and time-consuming using a minimally invasive approach. Laparoscopic surgery has become the standard practice for LLR, 34,35 despite inconclusive results from the only randomised controlled trial (ORANGE II) that compared open LLR (O-LLR) with laparoscopic LLR (L-LLR). 36 The study failed to recruit, partly owing to an absence of surgical equipoise reflected in a consensus statement by the International Consensus Conference for laparoscopic liver resections that L-LLR should be considered standard practice.
34
Three non-matched retrospective studies 37-39 and a propensity score-matched cohort study 40 have compared robotic LLR (R-LLR) with L-LLR. The robotic approach has not emerged from these studies as showing any additional benefits over L-LLR. Packiam et al found R-LLR gave inferior clinical outcomes and increased cost compared with L-LLR. 39 Kim et al reported equivalence in outcomes but longer operating time with R-LLR (403.8 mins) compared with L-LLR (245.9 mins); p<0.001. 38 In a small retrospective comparison of heterogeneous groups, Lee et al reported comparable outcomes between R-LLR and L-LLR. 37 Finally, Salloum et al reported comparable outcomes between the two groups, but after propensity score-matching, R-LLR had a longer operating time (203 mins) than L-LLR (140 mins); p= 0.02. 41 As with L-LLR, the use of robotic surgery may struggle to demonstrate clear benefits of its laparoscopic counterpart.
Non-anatomical sectionectomies
However, laparoscopic surgery is not well-suited to resection of the superior-posterior (S-P) Sections IVa, VII and VIII. First, access is difficult as rigid laparoscopic instruments are fulcrumed against the costal margin. Second, the delicate hepatocaval dissection required during mobilisation of the right hemi-liver risks major uncontrolled bleeding. Both these issues can, to some extent, be overcome by endo-wristed movements and tremor filtration of the robot, respectively.
Several groups have reported that robotic resection of the P-S segments is technically easier than with laparoscopic surgery. [41] [42] [43] [44] [45] Trosis et al compared unmatched liver resections performed laparoscopically (223) vs robotically (40) from two institutions. Robotic surgery permitted a higher rate of parenchymal-preserving surgery to be performed, both overall (37% vs 16.1%) and considering only P-S segments (55% vs 34.1%; p= 0.019). 42 The strategy of conservative, parenchymal-sparing but oncologically effective liver resection for colorectal liver metastasis in combination with chemotherapy has been shown to improve overall survival rates, 46,47 thus robotic surgery has the potential to improve disease-specific overall survival. The results from the P-S liver segment resection randomised controlled trial (ORANGE SEGMENTS trial) are awaited; however, robotic surgery may yet become established as the preferred minimally invasive approach. 
Major hepatectomy
Several groups have reported that robotic resection of the P-S segments is technically easier than with laparoscopic surgery
for LLR and non-anatomical resections from Segments II-VI, despite lack of evidence from prospective randomised controlled trials. In these procedures, robotic surgery may only be able to offer the additional benefit of completing the surgery in purely minimally invasive fashion. Countered with the increased cost and operating time associated with robotic surgery, its role in this instance should be questioned. Laparoscopic surgery for major hepatectomies is currently under evaluation in ongoing randomised controlled trials, and its superiority over open resection has not been ascertained. Whether robotic surgery for major hepatectomies, therefore, should be measured against the 'gold standard' of laparoscopic or open surgery is debatable until the results of ongoing randomised controlled trials are available. Although certain steps in the procedure such as hepatocaval and portal dissection may well be easier with the robotic approach compared with the laparoscopic approach, whether this translates into clinically important improvements outcomes remains to be seen. Non-anatomical resections from superior posterior sections of the liver have much to gain from a minimally invasive approach but are particularly challenging with a laparoscopic approach. Anecdotal evidence suggests that robotic surgery may have meaningful advantages over laparoscopic surgery -in this particular instance, permitting a purely minimally invasive parenchymal-preserving resection.
